Shionogi & Co., Ltd.

4507.T
Drug Manufacturers - Specialty & Generic
2026/11/11 12:12 Updated
Market Cap: $16.5B (¥2.6T)
Stock Price: $19.43 (¥3,080)
Exchange Rate: 1 USD = ¥158.48

Borrowing of a Bridge Loan in Connection with the Acquisition of IntraBio Inc.

In connection with making IntraBio Inc. a wholly owned subsidiary, Shionogi & Co., Ltd. borrowed a 3,000 hundred million yen bridge loan from Sumitomo Mitsui Banking Corporation. The agreement date and execution date are both 2026-11-10. The final repayment date is 2027-10-29. The loan is planned to be refinanced into medium- to long-term funding before the repayment date. The impact on consolidated results for the fiscal year ending March 2027 is estimated to be minimal.

Importance:
Page Updated: November 10, 2026
IR Disclosure Date: November 10, 2026

Key Figures

  • Borrowed Amount: 3,000 hundred million yen
  • Agreement Date: 2026-11-10
  • Final Repayment Date: 2027-10-29

AI要約

Overview

Shionogi & Co., Ltd. has procured a 3,000 hundred million yen bridge loan from Sumitomo Mitsui Banking Corporation in connection with making IntraBio Inc. a wholly owned subsidiary. The agreement date and execution date are both 2026-11-10, and the final repayment date is 2027-10-29. The funds will be used for acquisition financing, and the company plans to refinance into medium- to long-term funding before the repayment deadline.

Financial Impact and Outlook

The borrowing is expected to have a minimal impact on consolidated results for the fiscal year ending March 2027, and given the nature of the financing, the short-term financial burden is considered limited. Since the repayment and refinancing schedule could affect future capital policy and financial strategy, additional disclosures should be monitored.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Shionogi & Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →